Clinical Study

A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis (Ocarina)

Posted Date: Oct 7, 2019

  • Investigator: Lawrence Goldstick
  • Specialties: Multiple Sclerosis, Neurology
  • Type of Study: Drug

A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis

Criteria:

Patients With Multiple Sclerosis Previously Treated With Ocrelizumab For At Least One Year, Or Patients Who Have Never Received Ocrelizumab

Keywords:

Primary Progressive Ms, Relapsing Remitting Ms

For More Information:

Melissa Gilchrist
9375355014
melissa.gilchrist@uchealth.com